[ad_1]
“The United States has reached an early but important milestone today, with agencies reporting that more than one million people have received the first dose of COVID-19 since vaccination began 10 days ago,” Redfield said.
Chief Advisor to Operation Warp Speed, the Federal Government’s Vaccine Development and Distribution Program, Dr. Moncef Slaoui told reporters that the goal of vaccinating 20 million by the end of this month is unlikely to be met. people.
However, he said the US still hopes to meet the target of vaccinating 100 million by the end of the first quarter of 2021. people and another 100 million in the second quarter.
3 million were distributed in the United States last week. Dosage of the vaccine developed by the German company BioNTech and the American pharmaceutical giant Pfizer.
The Pfizer-BioNTech vaccine became the first to be approved by the US Food and Drug Administration (FDA). Vaccination with this vaccine in the United States began on December 14.
On December 18, the FDA approved the distribution of the second COVID-19 vaccine, developed by Moderna.
It is planned to distribute 6 million. Modern doses of vaccine and another 2 million. Pfizer-BioNTech dosage.
The United States is the country most affected in the world by a pandemic. More than 320,000 people have already died from the coronavirus infection in the country. people. COVID-19 is expected to be the leading cause of death in Americans in 2020, surpassing heart disease and cancer.
The vaccine is given first to healthcare workers and residents of nursing and long-term care facilities who are most at risk. During the next phase of the vaccination program, people over 75 years of age and employees of essential establishments will be vaccinated.
[ad_2]
